Doctors raise the importance of HPV vaccination to prevent cervical and a few other cancers
Vaccinating girls aged nine to 14 years against the Human Papillomavirus (HPV) is crucial for prevention of cervical cancers and a few other cancers. But equally important is vaccinating boys against HPV for a number of reasons, according to doctors.
There are three reasons why boys should also be vaccinated against HPV, Jayashree N., gynaecologic oncologist and associate professor, Cancer Institute (WIA), said. 'First, it can cause cancers in men too. Secondly, they could transmit the virus to women, and thirdly, there is no screening test for men.'
Somu Sivabalan, consultant Paediatrician and Pulmonologist, Rainbow Children's Hospital, explained that HPV being a sexually transmitted infection, it could spread from men. It could cause genital warts and precancerous changes. 'The primary target for HPV vaccination are girls aged nine to 14. Boys of the same age group are the secondary target for the vaccination,' he said.
The doctors, who spoke at 'Conquer HPV and Cancer Conclave 2025', stressed that HPV was not limited to cervical cancer alone. It was associated with cancers of the vulva, vagina, anus in women and cancers of the penis, anus and oropharynx in men. The conclave was organised in Chennai on Tuesday as a part of a nationwide public health initiative led by Serum Institute of India.
Dr. Jayashree said that vaccination and screening are the two pillars to prevent cervical cancers. Countries such as Australia, New Zealand, Canada, United States of America as well as European countries had an HPV vaccination programme as a result of which the incidence of cervical cancers has reduced, she said.
Discussing the safety of the vaccine, Dr. Jayashree noted that Cancer Institute had administered 3,500 doses of the vaccine so far, and there had been no side effects. B. Sarath Balaji, senior Paediatric Pulmonologist and associate professor, Institute of Child Health, said that except for mild pain, redness in the site and mild fever, there had been no major side effects. He added that there was greater awareness among parents in cities about the vaccine.
S. Vijaya, head of department and professor, ESIC Medical College and Hospital, Chennai, stressed the importance of taking time to counsel parents about the importance of the vaccine. Members of the Federation of Obstetric and Gynecological Societies of India were involved in creating awareness and training for doctors.
Kavitha Sukumar, associate professor, Surgical Oncology, Institute of Obstetrics and Gynaecology, said screening for cervical cancer is simple. 'We have HPV DNA testing and pap smear. Now, self testing kits are also available,' she said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
10 hours ago
- Hans India
HPV adding to the rise in cancer cases among Indian youth
A growing number of oncologists across India have expressed concern over Human Papillomavirus (HPV) becoming a major contributing factor in the rise of cancers in young Indians, particularly among those in their twenties and thirties. With increasing cases of cervical, oral, and oropharyngeal cancers linked to HPV infection, experts believe India is on the brink of a preventable cancer crisis if urgent measures are not implemented. Dr Ashish Gupta, Chief of Medical Oncology at Amerix Cancer Hospital, New Delhi, said, 'HPV-related cancers are striking far earlier than we used to see. Patients in their twenties are coming in with cervical, oral, and throat cancers -- many of which could have been avoided entirely with timely vaccination and proper awareness.' 'What's most heartbreaking is that HPV is preventable, yet many families and individuals are not even aware of the risk,' Dr Gupta said. Unlike other cancers that develop over decades, HPV-related cancers in young people often progress rapidly and silently. Prevention through vaccination and early screening should be treated with the same urgency as any national health emergency. 'We need a focused, stigma-free, countrywide campaign that reaches schools, colleges, and parents,' Gupta said. The virus, which spreads primarily through intimate skin-to-skin contact, is known to be one of the most common sexually transmitted infections globally. While the body clears most HPV infections on its own, certain high-risk strains can persist and lead to cancer. In women, it is the leading cause of cervical cancer, while in men and women alike, it is now strongly linked to oral, anal, and throat cancers. What troubles experts further is the lack of awareness and the social stigma that surrounds HPV discussions in India -- leading to poor vaccination rates and negligible screening coverage. Dr Shubham Garg, senior oncologist at Dharamshila Narayana super speciality hospital, said, 'HPV-related cancers don't give you many symptoms early on. That's why routine screening is so vital. A young woman with no symptoms may already have precancerous changes in the cervix. Similarly, oral HPV infections in men often go unnoticed until they present with full-blown tumours. Without education, vaccination, and routine checkups, we're allowing preventable cancers to spread unchecked.' Currently, India does not have a national HPV vaccination program for all adolescents, although the vaccines are approved and available in private settings. Global studies have proven that vaccinating both boys and girls before they become sexually active significantly reduces HPV transmission and related cancers. Experts believe that adopting universal HPV immunization for preteens, along with catch-up vaccinations for older teens and young adults, is the most effective strategy to curb this epidemic. However, vaccination alone isn't enough.
India Gazette
13 hours ago
- India Gazette
From space medicine to DNA Vaccines: Union Minister Jitendra Singh calls for synergized, inclusive healthcare model for Viksit Bharat 2047
New Delhi [India], June 29 (ANI): While delivering a thought-provoking keynote address at the Doctor's Day Conclave organized by the ET Times Now, Union Minister of State (Independent Charge) for Science & Technology Jitendra Singh, emphasized that India stands at the crossroads of a health-tech revolution and at the threshold of a grand new chapter, with its economy moving from the 10th to the 4th largest globally and the further ascent continuing. According to a release from the Ministry of Science and Technology, the Minister cited Indian astronaut Shubhanshu Shukla's mission to the International Space Station, carrying indigenous life science kits, as a milestone that may soon give birth to a new medical discipline: Space Medicine. Jitendra Singh called for a 'synergized, inclusive and futuristic healthcare ecosystem' in alignment with the vision of Viksit Bharat @2047. 'Very soon, we might have a dedicated stream in medical academics called Space Physicians. This is the future we must be ready for,' said Jitendra Singh. Addressing the theme of health and demographic change, the Minister spoke of India facing a 'bi-phasic challenge' -- a rising number of elderly citizens due to increased life expectancy, alongside a youthful population. He explained: 'While more than 70% of India is under 40, the elderly population is also growing rapidly. In 1947, the average life span was 50-55 years; today it is nearing 80,' the release added. Jitendra Singh noted the dual burden of disease, as India simultaneously tackles both communicable and non-communicable illnesses, particularly in the post-COVID era. To address this, he stressed mass screening, early detection, and prevention, calling for greater public-private partnerships and optimal use of technologies like AI, telemedicine, and machine learning, the release added. Highlighting India's recent global achievements, Jitendra Singh proudly stated that India has emerged as a global leader in preventive and precision healthcare. He noted that India developed the world's first DNA vaccine for COVID-19 and an HPV vaccine to help prevent cervical cancer. Further, India successfully conducted its first gene therapy trial for haemophilia, with the results published in the prestigious New England Journal of Medicine, the release added. The Minister also announced the launch of Nafithromycin, the country's first indigenously developed antibiotic molecule, marking a significant milestone in India's pharmaceutical innovation landscape. He attributed these successes to early-stage collaboration with private industry, stating 'These achievements were possible because of seamless integration of public and private sectors from the outset.' Touching upon the need for integrated institutions, Jitendra Singh revealed that IIT Kanpur and IISc Bengaluru are planning to establish medical schools within their campuses. He also lauded India's affordable healthcare models like Ayushman Bharat and institutions like Sree Chitra Tirunal Institute in Trivandrum, which integrates research, manufacturing, and clinical care, the release added. In the context of cancer care, Jitendra Singh emphasized India's move toward targeted radiation therapy and highlighted Tata Memorial Centre as a pioneer in 100% digital and cashless hospital systems. He also shed light on India's hygiene innovations during massive public gatherings like Kumbh Mela, where radiation-based faecal sludge treatment plants (FSTPs)ensured sanitation for over 40 crore pilgrims without health hazards. On climate-related health resilience, Jitendra Singh mentioned the recently launched Mission Mausam, focusing on early warning systems for health-related impacts of climate disasters. Concluding his address, Jitendra Singh underscored the need for a transformative approach to India's healthcare future. He called for wider synergy across sectors, emphasizing the importance of collaboration between academia, research institutions, industry, and government. He also advocated for early-stage integration of the private sector in both research and healthcare delivery to ensure sustainability and scalability. Furthermore, he urged institutional innovation, citing proposals by premier institutes like IIT Kanpur and IISc Bengaluru to establish medical schools within their campuses -- a step he believes will foster interdisciplinary excellence and create a new model of holistic education and healthcare, the release added. 'Let us not hand over everything to the technocrats. A bit of the doctor must remain. We must carry forward both the science and the soul of medicine,' he said. (ANI)
Time of India
13 hours ago
- Time of India
HPV Vaccine Not Just For Girls, Boys Should Get It Too: Doctor
1 2 Nagpur: "HPV vaccines are not only for girls. boys from 9 to 26 years of age should also take them. HPV isn't just about cervical cancer — it can cause many other cancers in both men and women," said Dr Sanjay Marathe, leading paediatrician and vaccination expert. He shared his views exclusively with TOI on the sidelines of the 'Conquer HPV & Cancer Conclave 2025'. Dr Marathe explained that the Human Papillomavirus (HPV) can cause five types of cancers in women — cervix, vulva, vagina, anus, and throat (oropharynx). In men, it's linked to three types of cancers — penis, anus, and throat. "The good news is that HPV vaccines, once given properly, provide almost 100% protection against these cancers," Dr Marathe said. He pointed out that many organisations and NGOs are giving one dose of the HPV vaccine under CSR (corporate social responsibility) drives, especially in rural areas. "But people should remember that the second dose is equally important. It can be taken any time after six months of the first dose," he added. Currently, experts believe one dose might be enough in future if mass vaccination starts across India. "But till then, people should consult their doctors and complete both doses. Govt support is crucial for large-scale HPV vaccination," Dr Marathe said. Parag Deshmukh, executive director of Serum Institute of India, said the HPV vaccine available in India is "one of the best and most affordable in the world." He added, "It's made right here in India, making it accessible for our people." Highlighting women's health concerns, gynaecologist Dr Sangeeta Tajpuriya said, "Cervical cancer is the second leading cancer among women in India. Early vaccination can save thousands of lives." Dr Charu Baheti stressed the need for awareness among parents. "Parents must understand that HPV vaccines are safe and effective for boys and girls. Early vaccination before sexual exposure offers the best protection," she said. The conclave, organised by the Serum Institute of India, is part of a nationwide drive to spread awareness about HPV-related cancers and the benefits of vaccination. The campaign will continue in other cities in the coming months. HPV VACCINE IS GENDER NEUTRAL * Cervical cancer ranks as the 2nd leading cause of female cancer in India * Women at risk of cervical cancer (aged over 15 yrs) is 5.14 crore * New cervical cancer cases annually: 1,23,907 * Annual cervical cancer deaths: 77,348
